SCHEMBL2928853

SCHEMBL2928853

Cc1cccc(C)c1NC12CC3CC(CC(C3)C1)C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.43
EPHX2 P34913 3/20 0.41
FAAH O00519 2/20 0.41
GRIN2D O15399 2/20 0.40
GRIN3B O60391 2/20 0.40
GRIN1 Q05586 2/20 0.40
GRIN2A Q12879 2/20 0.40
GRIN2B Q13224 2/20 0.40
GRIN2C Q14957 2/20 0.40
GRIN3A Q8TCU5 2/20 0.40
SIGMAR1 Q99720 3/20 0.40
P2RX7 Q99572 3/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA13 Q8N1Q1 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3711347 0.79 SIGMAR1 (0.53) CNR2EPHX2FAAHGRIN2DGRIN3B
SCHEMBL22002226 0.72 P2RX7 (0.48) CNR2EPHX2P2RX7ALDH1A1LMNA
SCHEMBL7977522 0.72 NPC1 (0.46) EPHX2ALDH1A1LMNATSHRL3MBTL1
SCHEMBL138594 0.69 EPHX2 (0.56) EPHX2FAAHP2RX7ALDH1A1TSHR
SCHEMBL21873552 0.69 SIGMAR1 (0.40) CNR2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL15656865 0.69 SIGMAR1 (0.40) CNR2EPHX2FAAHGRIN2DGRIN3B
SCHEMBL15657435 0.69 MEN1 (0.39) CNR2EPHX2FAAHGRIN2DGRIN3B
Hydrochloric Acid SCHEMBL27845477 0.68 EPHX2 (0.54) EPHX2FAAHSIGMAR1P2RX7ALDH1A1
SCHEMBL16884330 0.68 TRPV6 (0.56) CNR2EPHX2P2RX7ALDH1A1
SCHEMBL8866918 0.68 GRIN2D (0.43) CNR2EPHX2FAAHGRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8901336-B2 Catalysts, methods of making catalysts, and methods of use UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2014-12-02 US disclosed
US-8901336-B2 Catalysts, methods of making catalysts, and methods of use UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2014-12-02 US disclosed
US-8901336-B2 Catalysts, methods of making catalysts, and methods of use UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2014-12-02 US disclosed
US-20130060056-A1 CATALYSTS, METHODS OF MAKING CATALYSTS, AND METHODS OF USE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2013-03-07 US disclosed
US-20130060056-A1 CATALYSTS, METHODS OF MAKING CATALYSTS, AND METHODS OF USE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2013-03-07 US disclosed
US-20130060056-A1 CATALYSTS, METHODS OF MAKING CATALYSTS, AND METHODS OF USE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2013-03-07 US disclosed
EP-1303525-B1 PRODUCTION OF NOVEL PHOSPHANE LIGANDS AND USE IN CATALYTICAL REACTIONS EVONIK DEGUSSA GMBH (DE) 2010-09-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130060056-A1 CATALYSTS, METHODS OF MAKING CATALYSTS, AND METHODS OF USE SOD1, CAT, APEX1 CNR2 4301/4885EPHX2 2695/4885FAAH 3973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.